Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Mem. Inst. Oswaldo Cruz ; 112(7): 469-473, July 2017. tab
Article in English | LILACS | ID: biblio-841816

ABSTRACT

BACKGROUND Hepatopulmonary syndrome (HPS) is defined as an oxygenation defect induced by intrapulmonary vasodilation in patients with liver disease or portal hypertension. It is investigated in patients with liver cirrhosis and less frequently in those with portal hypertension without liver cirrhosis, as may occur in hepatosplenic schistosomiasis (HSS). OBJECTIVES To investigate the prevalence of HPS in patients with HSS, and to determine whether the occurrence of HPS is influenced by concomitant cirrhosis. METHODS We evaluated patients with HSS with or without concomitant liver cirrhosis. All patients underwent laboratory testing, ultrasound, endoscopy, contrast echocardiography, and arterial blood gas analysis. FINDINGS Of the 121 patients with HSS, 64 were also diagnosed with liver cirrhosis. HPS was diagnosed in 42 patients (35%) and was more frequent among patients with concomitant liver cirrhosis than in those without cirrhosis (42% vs. 26%), but the difference was not significant (p = 0.069). HPS was more common in those with spider naevi, Child-Pugh classes B or C and high model for end stage liver disease (MELD) scores (p < 0.05 each). MAIN CONCLUSIONS The prevalence of HPS was 35% in this study. The occurrence of liver cirrhosis concomitantly with HSS may have influenced the frequency of patients presenting with HPS.


Subject(s)
Humans , Male , Female , Middle Aged , Schistosomiasis mansoni/complications , Hepatopulmonary Syndrome/complications , Hepatopulmonary Syndrome/diagnosis , Hepatopulmonary Syndrome/epidemiology , Liver Cirrhosis/parasitology , Serial Cross-Sectional Studies , Prospective Studies
2.
Arq. bras. cardiol ; 100(4): 376-785, abr. 2013. ilus, tab
Article in Portuguese | LILACS | ID: lil-674193

ABSTRACT

FUNDAMENTO: O ecoDopplecardiograma (Eco) tem-se firmado como método não invasivo de excelente acurácia no rastreio de hipertensão portopulmonar (HPP) e pesquisa dos shunts intrapulmonares (SIP) na doença hepática crônica (DHC). Nesta última década, concretizou-se o Eco como de fundamental importância no diagnóstico da cardiomiopatia cirrótica (CMC). OBJETIVO: Realizar uma revisão sistemática envolvendo artigos relevantes sobre a temática: o Eco na DHC. MÉTODOS: Em novembro de 2011, realizou-se uma revisão sistemática a partir das bases de dados da Pubmed, LILACS e SciELO, sendo relatadas as características dos estudos selecionados. RESULTADOS: Foram encontrados 204 artigos a partir da busca de descritores e um termo livre, sendo 179 da Pubmed, 21 da LILACS e 01 da SciELO. Destes, foram selecionados 22 artigos para revisão sistemática, não sendo possível, pois, fazer uma meta-análise devido à heterogeneidade dos mesmos. CONCLUSÃO: O Eco deve fazer parte da estratificação da DHC para o rastreio de HPP, SIP e da CMC, já que a maioria das vezes, o diagnóstico dessas complicações ocorre nos pacientes na fila de transplante hepático.


BACKGROUND: Doppler echocardiography (Echo) is a non-invasive method of excellent accuracy to screen portopulmonary hypertension (PPH) and to assess intrapulmonary shunts (IPS) in chronic liver disease (CLD). In the past decade, Echo proved to play a fundamental role in the diagnosis of cirrhotic cardiomyopathy (CCM). OBJECTIVE: To perform a systematic review of relevant articles on the subject 'Echo in CLD'. METHODS: In November 2011, a systematic review was performed in the PubMed, LILACS and SciELO databases, and the characteristics of the studies selected were reported. RESULTS: The search based on descriptors and free terms obtained 204 articles (179 in Pubmed, 21 in LILACS, and 1 in SciELO). Of those 204 articles, 22 were selected for systematic review. A meta-analysis could not be performed because of the heterogeneity of the articles. CONCLUSIONS: Echo should be part of CLD stratification for screening PPH, IPS and CCM, because, most of the time, such complications are diagnosed only when patients are already waiting for a liver transplant.


Subject(s)
Female , Humans , Male , Cardiomyopathies , Liver Cirrhosis , Chronic Disease , Echocardiography/trends
SELECTION OF CITATIONS
SEARCH DETAIL